These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17582853)

  • 1. Weight-loss drug for obese dogs.
    FDA Consum; 2007; 41(2):4. PubMed ID: 17582853
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA approves first canine diet drug.
    Nolen RS
    J Am Vet Med Assoc; 2007 Mar; 230(5):641-2. PubMed ID: 17380625
    [No Abstract]   [Full Text] [Related]  

  • 3. Believes diet drug use ignores cause of pet obesity.
    Stuart B
    J Am Vet Med Assoc; 2007 Apr; 230(8):1144. PubMed ID: 17514838
    [No Abstract]   [Full Text] [Related]  

  • 4. An evidence-based review of the use of nutraceuticals and dietary supplementation for the management of obese and overweight pets.
    Roudebush P; Schoenherr WD; Delaney SJ
    J Am Vet Med Assoc; 2008 Jun; 232(11):1646-55. PubMed ID: 18518805
    [No Abstract]   [Full Text] [Related]  

  • 5. Biologic activity of dirlotapide, a novel microsomal triglyceride transfer protein inhibitor, for weight loss in obese dogs.
    Wren JA; King VL; Campbell SL; Hickman MA
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():33-42. PubMed ID: 17567513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of dirlotapide in the management of obese dogs evaluated in two placebo-controlled, masked clinical studies in North America.
    Wren JA; Ramudo AA; Campbell SL; King VL; Eagleson JS; Gossellin J; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():81-9. PubMed ID: 17567518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dirlotapide: a review of its properties and role in the management of obesity in dogs.
    Wren JA; Gossellin J; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():11-6. PubMed ID: 17567510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of dirlotapide in dogs.
    Wren JA; King VL; Krautmann MJ; Gossellin J; Kerlin RL; Hickman MA; Schmahai TJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():43-54. PubMed ID: 17567514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety evaluation and treatment affect of LY2190416, a CB-1 antagonist/inverse agonist in growing beagle dogs.
    Nunamaker E; Newhall K; Thompson C; Lucas A; Owens J; Sherman JG
    J Vet Pharmacol Ther; 2011 Dec; 34(6):577-82. PubMed ID: 21323931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine obesity: an overview.
    Gossellin J; Wren JA; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():1-10. PubMed ID: 17567509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orlistat half the dose without a prescription: new status. In excess body weight: often uncomfortable and don't expect miracles. Frequent gastrointestinal disturbances for a weight loss of a few kilos. Better to encourage dietary measures, exercise and individualised support.
    Prescrire Int; 2009 Jun; 18(101):101. PubMed ID: 19637413
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-obesity drugs: to be or not to be?
    Dvorak RV; Sharma AM; Astrup A
    Obes Rev; 2010 Dec; 11(12):833-4. PubMed ID: 21054758
    [No Abstract]   [Full Text] [Related]  

  • 13. Medications for weight reduction.
    Bray GA
    Endocrinol Metab Clin North Am; 2008 Dec; 37(4):923-42. PubMed ID: 19026940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-fat high-fibre diet and mitratapide on body weight reduction, blood pressure and metabolic parameters in obese dogs.
    Peña C; Suarez L; Bautista-Castaño I; Juste MC; Carretón E; Montoya-Alonso JA
    J Vet Med Sci; 2014 Sep; 76(9):1305-8. PubMed ID: 24920548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of starting condition score to estimate changes in body weight and composition during weight loss in obese dogs.
    German AJ; Holden SL; Bissot T; Morris PJ; Biourge V
    Res Vet Sci; 2009 Oct; 87(2):249-54. PubMed ID: 19303120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mitratapide on body composition, body measurements and glucose tolerance in obese Beagles.
    Dobenecker B; De Bock M; Engelen M; Goossens L; Scholz A; Kienzle E
    Vet Res Commun; 2009 Dec; 33(8):839-47. PubMed ID: 19544001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue gene expression in obese dogs after weight loss.
    Leray V; Serisier S; Khosniat S; Martin L; Dumon H; Nguyen P
    J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):390-8. PubMed ID: 18477322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity symposium].
    Overgaauw P
    Tijdschr Diergeneeskd; 2008 Jan; 133(1):36-7. PubMed ID: 18260564
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of osteoarthritis and obesity: current understanding of the relationship and benefit of obesity treatment and prevention in the dog.
    Marshall W; Bockstahler B; Hulse D; Carmichael S
    Vet Comp Orthop Traumatol; 2009; 22(5):339-45. PubMed ID: 19750285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for the obese patient.
    Dickerson LM; Carek PJ
    Prim Care; 2009 Jun; 36(2):407-15. PubMed ID: 19501251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.